Other ways to search: Events Calendar | UTHSC

Le Bonheur to test promising new drug on babies battling RSV


Le Bonheur is the “main place” for the worldwide test of a antiviral drug known as ALS-008176, which could redefine how RSV cases are handled, said Dr. John DeVincenzo, medical director, molecular and viral diagnostics at Le Bonheur. He’s the lead author of a study — published last week in the New England Journal of Medicine — that prompted the federal Food and Drug Administration to approve the test on babies. “This is fantastic in a few ways,” said DeVincenzo, who also is a professor of pediatrics and of microbiology, immunology and biochemistry at the University of Tennessee Health Science Center. “This is the most active and potent medicine that anybody has ever assessed … to reduce the RSV virus.”

Top Publishers